CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
11,670,702
Share change
+164,386
Total reported value
$42,130,000
Price per share
$3.61
Number of holders
26
Value change
+$102,138
Number of buys
11
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q4 2016

As of 31 Dec 2016, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,670,702 shares. The largest 10 holders included SV Life Sciences Advisers, LLC, Clarus Ventures, LLC, FMR LLC, Camber Capital Management LLC, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, GREAT POINT PARTNERS LLC, SPHERA FUNDS MANAGEMENT LTD., WELLINGTON MANAGEMENT GROUP LLP, and VANGUARD GROUP INC. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.